For Myeloma Diagnosis, Urine Tests May Be Better Than Serum, Study Finds
Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Light chain myeloma and detection of free light chains in serum and urine of dogs and cats - Harris - 2021 - Journal of Veterinary Internal Medicine - Wiley Online Library
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology
In response to: Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study | Blood Cancer Journal
PDF) Comparison of the free and total light chain assays in serum and urine samples with immunofixation electrophoresis for detecting monoclonal proteins in patients with monoclonal gammopathy
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
TECHNICAL BULLETIN
Management of Monoclonal Gammopathy of Uncertain Significance | SpringerLink
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Light and heavy chain deposition revealed by repeat renal biopsy after inconclusive initial biopsy - Ramy M Hanna, Marina Barsoum, Andrae Vandross, Jonathan Zuckerman, Brian Cone, Shih-Fan Sun, Anthony Ghobran, Samuel Olanrewaju,
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
View of Screening for diabetic nephropathy: take your blinkers off | British Journal of Diabetes
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
Accuracy of determination of free light chains (Kappa and Lambda) in plasma and serum by Swedish laboratories as monitored by external quality assessment - ScienceDirect
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
Demystifying Serum Free Light Chains – a guide for primary care - Manchester University NHS Foundation Trust
free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site
Frontiers | Can urine studies be replaced by serum free light chains measurements to assign responses in multiple myeloma patients?
SERUM FREE LIGHT CHAIN ASSAY | PPT
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
![PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/3-Table2-1.png "PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar")